CoChat

Epithelial Mutations in Endometriosis: Link to Ovarian Cancer

Open access
Bulun, Serdar E, Wan, Yong, Matei, Daniela · 2019 · Endocrinology
Cited by 104

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Abstract

Epidemiologic and histopathologic associations between endometriosis and epithelial ovarian cancer have been reported; however, the underlying molecular and cellular mechanisms are not well understood.A possible genetic link has been suggested in recent publications.Driver mutations in PIK3CA, KRAS, ARID1A, and other genes have been found in the epithelium of intrauterine endometrial tissue, ovarian and extraovarian pelvic endometriosis tissue, ovarian cancers associated with endometriosis (i.e., clear cell and endometrioid type), and other epithelial ovarian cancers.This makes sense because pelvic endometriosis occurs primarily as a result of retrograde menstruation and implantation of endometrial tissue fragments in ovarian inclusion cysts or extraovarian peritoneal or subperitoneal sites.Unlike epithelial cells, endometriotic stromal cells are mutation free but contain widespread epigenetic defects that alter gene expression and induce a progesterone-resistant and intensely inflammatory environment, driven by estrogen via estrogen receptor-b.The resulting increased estrogenic action in the stroma drives inflammation and sends paracrine signals to neighboring epithelial cells to enhance proliferation.In addition, massively high concentrations of estrogen in the ovary may exert an additional and direct genotoxic effect on DNA and cause accumulation of additional mutations and malignant transformation in initially mutated endometriotic epithelial cells in an ovarian endometrioma, which may initiate epithelial ovarian cancer.The same epithelial mutations and inflammatory processes in stroma are seen in extraovarian deep-infiltrating endometriosis, but carcinogenesis does not occur.We provide a focused review of the literature and discuss the implications of recent genetic breakthroughs linking endometriosis and ovarian cancer.(Endocrinology 160: 626-638, 2019) H istologically, pelvic endometriosis is defined as the presence of endometrium-like tissue in the ovary or pelvic peritoneum.In contrast to endometrial tissue, which consists of a substantial epithelial component that lines deep invaginations into the stroma, endometriotic tissue is composed primarily of stromal cells with scant and superficially located epithelial cells (1).Because ovarian cancer originates from epithelial cells, it is important to consider this histological distinction.Three independent groups using next-generation sequencing have identified mutations occurring in the epithelial cells of ovarian and extraovarian (deep-infiltrating) pelvic endometriosis samples from premenopausal women (2-4).No mutations were detected in the stromal cell component of endometriosis.Intriguingly, the epithelial cells of histologically normal intrauterine endometrial tissue from women with or without endometriosis also displayed a similar mutational profile (4).The epithelial mutations in endometriosis or endometrium included distinct driver mutations for ovarian cancer [e.g., in the PIK3CA, KRAS and ARID1A genes (2-4)].At first glance, these findings were puzzling because the direct

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/en.2018-00794

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 104

Metadata

Authors
Bulun, S. E., Wan, Y., & Matei, D.
Venue
Endocrinology
Published
2019-01-17
Volume
160
Issue
3
Pages
626-638
ISSN
  • 0013-7227 (ISSN-L)
  • 1945-7170
OpenAlex
W2910391678
Cited by
104
References
35
FWCI
11.15
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.